News | Radial Access | November 13, 2017

SCAI Launches TRAnsition for VALUE Radial Access Educational Initiative

Program looks to promote transradial access as the future of PCI procedures as the nation shifts to value-based healthcare

SCAI Launches TRAnsition for VALUE Radial Access Educational Initiative

November 13, 2017 — The Society for Cardiovascular Angiography and Interventions recently announced the launch of TRAnsition for VALUE, a multi-faceted educational initiative supported by Medtronic, to inform cardiologists, hospital administrators and cath lab staff about the benefits of expanding the adoption of transradial (wrist access) percutaneous coronary intervention (PCI) in the U.S.

Approximately 70 percent of PCI procedures in the U.S. are performed through transfemoral (groin area) access. While this approach is often successful, it is associated with challenges, including an increased risk of bleeding complications at the insertion site and a slower recovery process for the patient.

As the country’s healthcare system moves toward a value-based approach, TRAnsition for VALUE highlights the clinical and economic advantages of transradial intervention, which has increased from 16 to nearly 30 percent in the past decade. While not all patients can benefit from this approach, eligible patients may experience improved safety with reductions in major bleeding and vascular complications, increased comfort, a shorter hospital stay and lower risk of mortality.

Despite the potential benefits, usage rates among U.S. interventionalists remain lower than those in similar healthcare systems, with cardiologists in major European and Asian countries reporting transradial usage at over 70 percent. Research indicates that a lack of education and training has impacted U.S. transradial adoption rates.

“Value for your healthcare dollar is an increasingly important driving force in the current healthcare environment. It is demanded by patients, payers and regulators,” said Adhir Shroff, M.D., MPH, FSCAI, chair of TRAnsition for VALUE, and director, cardiovascular catheterization laboratories, University of Illinois. “The transradial approach represents an opportunity to provide value-based healthcare through improving outcomes for patients and streamlining care delivery within medical centers.”

In addition, the transradial approach increases hospital efficiency by allowing same-day discharge, reducing recovery time and hospital staffing needs, and decreasing the cost of care. It also may expand treatment options for those who may not be candidates for transfemoral access PCI, such as those who are obese, elderly or have orthopedic disabilities that make it difficult to lie flat.

“Transradial PCI is truly a patient-centric approach with undisputed clinical benefits and patient preference,” said Sunil V. Rao, M.D., FSCAI, associate professor of medicine, Duke University Medical Center, and co-chair of the initiative. “The issue has been a lack of training opportunities for physicians interested in adopting this approach. SCAI’s comprehensive TRAnsition for VALUE program offers the resources, training and opportunity to learn from the nation’s experts.”

The TRAnsition for VALUE education curriculum will be guided by the SCAI Quality Improvement Committee and supports SCAI’s consensus statement on transradial best practices. The primary education destination is a new website, TRAnsitionForVALUE.org, where visitors can register to receive custom education and training opportunities. The site will also host a modular, eight-part, quality improvement toolkit with accompanying webinars hosted by SCAI Quality Improvement experts on the following topics:

  • How Value-Based Healthcare Affects Your Clinical Practice;
  • The Clinical Benefits of Transradial Access;
  • The Economic Benefits of Transradial Access;
  • Femoral to Radial 101 – Where to Begin for MDs;  
  • Clinical Best Practices, Tips & Tricks for TRA Technique;
  • Rethinking Care Delivery in a TRA Cath Lab;
  • The Cath Lab Staff’s Role in TRA Adoption; and
  • Your TRA Support Network: How to Initiate Change

The TRAnsition for VALUE program will also be featured at the annual SCAI Scientific Sessions, as well as other regional events in partnership with hospitals and healthcare systems throughout the U.S.

Watch the VIDEO Update on U.S. Transradial Access Adoption With Sunil Rao at TCT 2015

Read "Radial Access, Same-Day Cardiac Procedure Could Save $300 Million Annually"

For more information: www.transitionforvalue.org

Related Content

Teleflex Launches Next-Generation Sympro Elite and Expro Elite Snares
Technology | Cath Lab | February 07, 2018
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
SCAI Advocacy Committee Highlights Reimbursement Reform Efforts in 2017
News | Cath Lab | January 30, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) highlighted the efforts of its Advocacy Committee...
IAC Releases Cardiovascular Catheterization Accreditation Program
News | Cath Lab | January 25, 2018
January 25, 2018 – The Intersocietal Accreditation Commission (IAC) announced the release of its Cardiovascular Cathe
Videos | Cath Lab | January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab | January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab | November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab | November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab | November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab | November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Overlay Init